On October 24, 2024, at the "2024 Northeast Asia (Shenyang) Talent Exchange Conference & China Potential Unicorn Enterprise Development Forum", the Great Wall Strategy Consultants released the "GEI China Potential Unicorn Enterprise Research Report 2024", which included the "China Potential Unicorn Enterprises List".

The report revealed that the number of China's potential unicorn enterprises surged from 296 in 2019 to 783 in 2023, with 301 new additions during this period. Kunshan Yiyuan was named on the list, ranking 398th overall.

Unicorn enterprises refer to startup companies characterized by rapid growth, scarcity, and high appeal to investors. As the pipeline for future unicorns, potential unicorn enterprises play an even more critical role in driving technological innovation, pioneering new frontiers and industries, as well as shaping new growth drivers and competitive advantages.

Kunshan Yiyuan's inclusion in this prestigious list signifies authoritative recognition of the company's technological sophistication, cutting-edge scientific attributes, business model, and growth potential. As one of China's emerging potential unicorns, Yiyuan will join its peers in representing new quality productive forces. Embracing the responsibility and mission of an industry leader, the company is committed to:

Pioneering future technological innovation

Accelerating the development of domestically-produced CT X-ray tubes

Ensuring independent controllability of core components for high-end medical equipment

Contributing to China's technological self-reliance and advancement